Diabetes drugs may help older adults slow frailty
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide (Ozempic) and liraglutide […]
